Sponsor or institution
Clinical trials and research at Eclipse Enterogenesis, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome
A study testing a novel XL1 device to help people with short bowel syndrome absorb nutrients better, potentially reducing reliance on intravenous nutrition.
-
XL1 device to gently lengthen the intestine and improve absorption for short bowel syndrome
A small implantable device called XL1 aims to gently stretch the remaining intestine to help children and adults with short bowel syndrome absorb more nutrients naturally.
-
Lengthening the intestine to help patients with Short Bowel Syndrome
This study is exploring a new way to help people with Short Bowel Syndrome by gently stretching their remaining small intestine, which could help them absorb more nutrients and reduce the need for expensive treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.